Market Trends– category –
-
Global Leukapheresis Market Growth Accelerates Driven by Cell Therapy, Oncology, and Transplant Demand
GlobeNewswire USA Overview This article summarizes a market research report from The Business Research Company. The report analyzes the global leukapheresis market, noting accelerated growth due to increasing demand in cell therapy, onco... -
Bone Biologics Reports Development Progress in Bone Regeneration, Secures $1.6M from Warrant Exercise
Markets Insider USA Overview Bone Biologics reported significant development progress in its bone regeneration therapeutics in its mid-year shareholder update for 2026. The company, focused on osteoconductive recombinant human proteins f... -
First-in-Human Diabetes Cell Therapy Shows Promising Initial Clinical Data
The Medicine Maker UK Overview The world's first human diabetes cell therapy has reportedly shown promising initial data in clinical trials. This therapy holds the potential to reduce insulin dependency in Type 1 diabetes patients by rep... -
BioLife Solutions Completes $1 Billion Acquisition to Bolster Cell Therapy Services
RegMedNet USA Overview BioLife Solutions has reportedly completed a $1 billion acquisition, aimed at significantly strengthening its cell therapy service offerings. As a key player in the cell therapy supply chain and manufacturing proce... -
Australian Government Delays National AI Regulatory Framework While Establishing New ‘Office of AI’ and Pledging Stronger Copyright Protections for Creators
Science Media Centre Australia Overview Australian Prime Minister Anthony Albanese announced a delay in implementing the national AI regulatory framework but concurrently pledged "the strongest possible protections" for creators against ... -
Median Technologies’ AI-Powered Lung Cancer Screening Software ‘eyonis® LCS’ Secures Dual FDA 510(k) Clearance and CE Mark
Business Wire France Overview Median Technologies, a French company, announced that its AI-driven medical device software (SaMD), eyonis® LCS, a lung cancer screening and early diagnosis support tool, received both FDA 510(k) clearance a... -
EU AI Act: High-Risk AI Systems Granted Grace Period Until 2028, While Generative AI Transparency Obligations Take Effect August 2, 2026
Eversheds Sutherland EU Overview The European Union's AI Act has extended compliance deadlines for high-risk AI systems until December 2027 or August 2028, but transparency obligations for generative AI output and deepfake content will a... -
TSMC Achieves Record $22 Billion Q2 Profit with 77% Surge on AI Chip Demand, Commits $100 Billion Additional Investment in Arizona, and Expands CoWoS Capacity by Over 50%
ServeTheHome Taiwan Overview TSMC, the world's largest contract chipmaker, reported a record net profit of $22 billion in Q2 2026, marking a 77% year-over-year increase, driven by booming AI chip demand. The company raised its full-year ... -
AI Data Centers Poised to Consume 20% of US Electricity by 2035 Amid Surging Demand and Infrastructure Innovation
Programs.com USA Overview AI data centers are projected to consume approximately 20% of total US electricity by 2035, up from an estimated 12% in 2030, driven by the explosive growth in AI workloads reaching 44 gigawatts by that time. Th... -
South Korea’s Songwon Establishes New Benchmark in Sustainable Polymer Additives with RSPO-Certified Antioxidant ‘SONGNOX 1076’, Commercial Sales Commencing Late 2026
ET Chemical News South Korea Overview Songwon Industrial of South Korea has launched 'SONGNOX 1076', the industry's first RSPO (Roundtable on Sustainable Palm Oil) certified antioxidant, setting a new benchmark in sustainable polymer add...
